Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Chronic kidney disease
•
Nephrology
•
Endocrinology
•
Primary Care
Do you recommend stopping a SGLT2i indefinitely if a patient with chronic kidney disease and diabetes develops euglycemic diabetic ketoacidosis?
Answer from: at Community Practice
I would. In my opinion, the risk of ketoacidosis will outweigh the possible benefit from SGLTs.
Comments
at CommonSpirit
Absolutely, I would stop SGLT as one episode shoul...
at Atrium Health Wake Forest Baptist Medical Center
I would, depending on the individual patient with ...
12214
12216
Sign In
or
Register
to read more
22632
Related Questions
What are some practical tips in distinguishing between metabolic bone disease due to chronic kidney disease and osteoporosis?
How do you approach patients who are inappropriately worried/fixated on a test result that is flagged as abnormal but not clinically significant?
How do you approach vitamin D supplementation in patients with chronic kidney disease, given the findings that vitamin D2 supplementation may lead to decreased conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3?
Is it a good practice to prescribe clonidine to take as needed for occasional severe blood pressure elevations?
Would you recommend the use of an ACE inhibitor to patients with Type 1 diabetes mellitus who are normotensive but have persistent moderate proteinuria?
Is it safe to use acarbose in patients with advanced chronic kidney disease?
Do you plan to initiate combination therapy with an SGLT-2 inhibitor and finerenone, instead of an SGLT-2 inhibitor alone, when treating patients with proteinuric chronic kidney disease and type 2 diabetes in light of the CONFIDENCE trial findings?
In outpatient primary care settings, would you recommend routinely checking Cystatin-C as a marker of renal function in older adults?
How do you approach counseling the family of a patient with advanced CKD and dementia when discussing the options and implications of starting dialysis?
What are some practical tips for when a patient's consistently stated goals of care do not correlate with their actions?
Absolutely, I would stop SGLT as one episode shoul...
I would, depending on the individual patient with ...